Company profile
Biosensors International Group, Ltd
Saving Lives Through Innovation
- Industry
- Medical Device
- Employees
- 508
- Headquarters
- Singapore
- Founded
- 1990
- Office locations
- 6
Biosensors International Group, Ltd company summary
Biosensors International Group, Ltd is a company in the Medical Device industry, headquartered in Singapore, founded in 1990. On LinkedIn the company has around 508 employees. The company lists 6 office locations. Its listed specialties include Cardiology medical device, Structural Heart, TAVI, Stents, Pioneering Technology.
What technology does Biosensors International Group, Ltd use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Biosensors International Group, Ltd
Biosensors International develops, manufactures and markets pioneering interventional cardiology devices. The BioMatrix™ DES family features Biolimus A9™ (BA9™), a highly lipophilic anti-restenotic drug designed for cardiovascular stent technologies patented by Biosensors, combined in a unique abluminal biodegradable polymer coating. BioMatrix Alpha™, the latest addition to the family, is a CoCr stent featuring an innovative hybrid design, thin struts and an advanced delivery system. BioFreedom™ demonstrated superior safety and efficacy vs BMS in High Bleeding Risk patients in the landmark LEADERS FREE trial and features a selectively micro-structured abluminal surface allowing polymer & carrier free delivery of BA9™. Recently Biosensors’ parent company made a significant investment into the rapidly growing field of structural heart disease intervention through the acquisition of the company New Valve Technology (NVT), the developers of the flagship product Allegra™ transfemoral TAVI system. Together, Biosensors and NVT will leverage our their respective innovative expertise in Cardiovascular and Structural Heart technologies. Our aim is to improve patients’ lives through pioneering medical technology that pushes the boundaries of innovation. Through our high quality medical devices we impact the lives we touch and we are committed to continued investment in the development of pioneering medical technology, robust clinical data and engineering new medical devices that will further benefit your patients.
Specialties
Where is Biosensors International Group, Ltd located?
Biosensors International Group, Ltd lists 6 office locations.
Compare companies similar to Biosensors International Group, Ltd
More companies in Medical Device.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Biosensors International Group, Ltd biosensors.com | Medical Device | 508 | 1990 | Singapore |
 Dentsply Sirona dentsplysirona.com | Medical Device | 11,298 | 1899 | Charlotte, North Carolina |
 Meril merillife.com | Medical Device | 6,937 | 2006 | Vapi, Gujarat |
 Varian varian.com | Medical Device | 7,543 | - | Palo Alto, CA |
 Transasia Bio-Medicals Ltd. transasia.co.in | Medical Device | 2,140 | - | Mumbai, Maharashtra |
 NuVasive globusmedical.com | Medical Device | 1,404 | - | San Diego, CA |
 3Shape 3shape.com | Medical Device | 1,929 | 2000 | Copenhagen, Copenhagen |
 Candela Medical candelamedical.com | Medical Device | 606 | 1970 | Marlborough, MA |
 SS Innovations International, Inc. ssinnovations.com | Medical Device | 462 | 2015 | Gurugram, Haryana |
 BTL Industries btlnet.com | Medical Device | 1,763 | 1993 | Stevenage, Hertfordshire |
 Benco Dental benco.com | Medical Device | 1,601 | 1930 | Pittston, Pennsylvania |
Frequently asked questions about Biosensors International Group, Ltd
What does Biosensors International Group, Ltd do?
Biosensors International develops, manufactures and markets pioneering interventional cardiology devices. The BioMatrix™ DES family features Biolimus A9™ (BA9™), a highly lipophilic anti-restenotic drug designed for cardiovascular stent technologies patented by Biosensors, combined in a unique abluminal biodegradable polymer coating. BioMatrix Alpha™, the latest addition to the family, is a CoCr stent featuring an innovative hybrid design, thin struts and an advanced delivery system. BioFreedom™ demonstrated superior safety and efficacy vs BMS in High Bleeding Risk patients in the landmark LEADERS FREE trial and features a selectively micro-structured abluminal surface allowing polymer & carrier free delivery of BA9™. Recently Biosensors’ parent company made a significant investment into the rapidly growing field of structural heart disease intervention through the acquisition of the company New Valve Technology (NVT), the developers of the flagship product Allegra™ transfemoral TAVI system. Together, Biosensors and NVT will leverage our their respective innovative expertise in Cardiovascular and Structural Heart technologies. Our aim is to improve patients’ lives through pioneering medical technology that pushes the boundaries of innovation. Through our high quality medical devices we impact the lives we touch and we are committed to continued investment in the development of pioneering medical technology, robust clinical data and engineering new medical devices that will further benefit your patients.
How many employees does Biosensors International Group, Ltd have?
Biosensors International Group, Ltd has around 508 employees on LinkedIn.
Where is Biosensors International Group, Ltd headquartered?
Biosensors International Group, Ltd is headquartered in Singapore.
Where does Biosensors International Group, Ltd have offices?
Biosensors International Group, Ltd lists 6 office locations, including Singapore, 619266, SG; Hillegom, 2182 DZ, NL; Jakarta Pusat, 10160, ID; Morges, 1110, CH; Tokyo, 100-0011, JP.
When was Biosensors International Group, Ltd founded?
Biosensors International Group, Ltd was founded in 1990.
Build a lead list from companies like Biosensors International Group, Ltd
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.